ARRY Stock Forecast 2025-2026
Distance to ARRY Price Targets
ARRY Price Momentum
10 Quality Stocks Worth Considering Now
Researching Array BioPharma (ARRY) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on ARRY and similar high-potential opportunities.
Latest ARRY Stock Price Targets & Analyst Predictions
Based on our analysis of 35 Wall Street analysts, ARRY has a neutral consensus with a median price target of $7.50 (ranging from $4.50 to $13.00). The overall analyst rating is Buy (7.8/10). Currently trading at $4.56, the median forecast implies a 64.5% upside. This outlook is supported by 13 Buy, 13 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Colin Rusch at Oppenheimer, projecting a 185.1% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
ARRY Analyst Ratings
ARRY Price Target Range
Latest ARRY Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for ARRY.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Apr 17, 2025 | Truist Securities | Jordan Levy | Buy | Reiterates | $7.00 |
| Mar 17, 2025 | RBC Capital | Christopher Dendrinos | Sector Perform | Initiates | $7.00 |
| Mar 6, 2025 | Barclays | Christine Cho | Overweight | Maintains | $8.00 |
| Mar 4, 2025 | UBS | Jon Windham | Buy | Maintains | $7.00 |
| Mar 3, 2025 | Truist Securities | Jordan Levy | Buy | Reiterates | $8.00 |
| Mar 3, 2025 | Susquehanna | Biju Perincheril | Neutral | Maintains | $6.00 |
| Feb 28, 2025 | Mizuho | Maheep Mandloi | Neutral | Maintains | $9.00 |
| Feb 28, 2025 | Oppenheimer | Colin Rusch | Outperform | Maintains | $13.00 |
| Feb 28, 2025 | Seaport Global | Tom Curran | Neutral | Downgrade | $0.00 |
| Feb 6, 2025 | Exane BNP Paribas | Moses Sutton | Neutral | Upgrade | $9.00 |
| Jan 10, 2025 | Susquehanna | Biju Perincheril | Neutral | Downgrade | $7.00 |
| Jan 8, 2025 | Wells Fargo | Michael Blum | Equal-Weight | Maintains | $7.00 |
| Dec 17, 2024 | Goldman Sachs | Brian Lee | Buy | Maintains | $11.00 |
| Nov 12, 2024 | Susquehanna | Biju Perincheril | Positive | Maintains | $9.00 |
| Nov 8, 2024 | Roth MKM | Philip Shen | Neutral | Maintains | $6.00 |
| Nov 8, 2024 | JP Morgan | Paul Coster | Overweight | Maintains | $15.00 |
| Nov 8, 2024 | Oppenheimer | Colin Rusch | Outperform | Maintains | $14.00 |
| Nov 8, 2024 | UBS | Jon Windham | Buy | Maintains | $10.00 |
| Nov 7, 2024 | Guggenheim | Joseph Osha | Neutral | Downgrade | $0.00 |
| Oct 22, 2024 | Piper Sandler | Kashy Harrison | Neutral | Maintains | $7.00 |
Array Technologies Inc. (ARRY) Competitors
The following stocks are similar to Array BioPharma based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Array Technologies Inc. (ARRY) Financial Data
Array Technologies Inc. has a market capitalization of $660.38M with a P/E ratio of 61.9x. The company generates $915.81M in trailing twelve-month revenue with a -26.2% profit margin.
Revenue growth is -19.4% quarter-over-quarter, while maintaining an operating margin of +8.7% and return on equity of -53.5%.
Valuation Metrics
Growth & Margins
Financial Health
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Array Technologies Inc. (ARRY) Business Model
About Array Technologies Inc.
Provides solar tracking solutions to optimize energy output.
The company designs and manufactures ground-mounted solar tracking systems that enhance the efficiency of solar energy capture. It generates revenue by selling these systems to a diverse clientele, including utility-scale developers, EPCs, and commercial users, all seeking to maximize their solar power investments.
Array Technologies is recognized for its advanced single-axis tracking technology, which allows solar panels to follow the sun's trajectory, improving energy capture. The company’s systems are durable and adaptable, making them suitable for various climates. By advancing solar tracking technology, Array Technologies plays a vital role in the renewable energy sector, contributing to reduced global CO2 emissions and supporting sustainable development.
Company Information
Sector
Technology
Industry
Solar
Employees
1,021
CEO
Mr. Kevin G. Hostetler
Country
United States
IPO Year
2010
Website
arraytechinc.comArray Technologies Inc. (ARRY) Latest News & Analysis
Array Technologies, Inc. (ARRY) Gains But Lags Market: What You Should Know
In the most recent trading session, Array Technologies, Inc. (ARRY) closed at $4.33, indicating a +0.93% shift from the previous trading day.
Latest News
ARRAY Technologies, Inc. Announces First Quarter 2025 Earnings Release Date and Conference Call
9 days agoARRAY Technologies, Inc. (Nasdaq: ARRY) will release Q1 2025 results on May 6, 2025, before market open, followed by a conference call at 8:00 a.m. ET.
ARRAY Technologies' upcoming earnings release and conference call could influence stock performance, providing insights into financial health and growth prospects in the solar sector.
ARRAY Technologies Appoints Nick Strevel as Senior Vice President of Product Management and Technical Sales
10 days agoARRAY appoints a veteran solar executive to head global product strategy and establish a new technical sales function, aiming to boost innovation and customer engagement.
Leadership changes in ARRAY's strategy can drive innovation and improve sales, potentially boosting growth and profitability, which may positively influence stock performance and investor sentiment.
Array Technologies, Inc. (ARRY) Stock Slides as Market Rises: Facts to Know Before You Trade
1 month agoArray Technologies, Inc. (ARRY) closed at $5.69, reflecting a decrease of 0.18% from the prior trading day.
A slight decline in Array Technologies' stock price may signal market volatility or investor sentiment shifts, impacting future trading decisions and investment strategies.
Array Technologies, Inc. (ARRY) closed at $6.08, up 0.33% from the previous day.
Array Technologies' slight price increase indicates potential stability or positive sentiment in its stock, which could influence trading decisions and market confidence.
Array Technologies, Inc. will host its Q4 2024 earnings conference call on February 27, 2025, at 5:00 PM ET, featuring key executives and analysts from major financial firms.
Array Technologies' earnings call signals key financial updates and strategic insights that could influence stock performance and investor sentiment. Key analysts will provide market perspectives.
ARRAY Technologies, Inc. Reports Financial Results for the Fourth Quarter and Full Year 2024
1 month agoThe company exceeded fourth quarter revenue guidance mid-point, achieved a record gross margin for the year, and demonstrated strong cash flow generation.
Exceeding revenue guidance and achieving record gross margins signal strong financial health, potentially boosting stock performance and investor confidence. Strong cash flow suggests effective operations.
Frequently Asked Questions About ARRY Stock
What is Array Technologies Inc.'s (ARRY) stock forecast for 2025?
Based on our analysis of 35 Wall Street analysts, Array Technologies Inc. (ARRY) has a median price target of $7.50. The highest price target is $13.00 and the lowest is $4.50.
Is ARRY stock a good investment in 2025?
According to current analyst ratings, ARRY has 13 Buy ratings, 13 Hold ratings, and 0 Sell ratings. The stock is currently trading at $4.56. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for ARRY stock?
Wall Street analysts predict ARRY stock could reach $7.50 in the next 12 months. This represents a 64.5% increase from the current price of $4.56. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Array Technologies Inc.'s business model?
The company designs and manufactures ground-mounted solar tracking systems that enhance the efficiency of solar energy capture. It generates revenue by selling these systems to a diverse clientele, including utility-scale developers, EPCs, and commercial users, all seeking to maximize their solar power investments.
What is the highest forecasted price for ARRY Array Technologies Inc.?
The highest price target for ARRY is $13.00 from Colin Rusch at Oppenheimer, which represents a 185.1% increase from the current price of $4.56.
What is the lowest forecasted price for ARRY Array Technologies Inc.?
The lowest price target for ARRY is $4.50 from at , which represents a -1.3% decrease from the current price of $4.56.
What is the overall ARRY consensus from analysts for Array Technologies Inc.?
The overall analyst consensus for ARRY is neutral. Out of 35 Wall Street analysts, 13 rate it as Buy, 13 as Hold, and 0 as Sell, with a median price target of $7.50.
How accurate are ARRY stock price projections?
Stock price projections, including those for Array Technologies Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.